CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
2.870
-0.120 (-4.01%)
At close: Dec 20, 2024, 4:00 PM
3.100
+0.230 (8.01%)
After-hours: Dec 20, 2024, 7:35 PM EST
CureVac Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CureVac stock have an average target of 10, with a low estimate of 4.00 and a high estimate of 16. The average target predicts an increase of 248.43% from the current stock price of 2.87.
Analyst Consensus: Hold
* Price targets were last updated on Sep 16, 2024.
Analyst Ratings
The average analyst rating for CureVac stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +457.49% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +457.49% | Aug 16, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +527.18% | Jul 3, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +39.37% | Apr 25, 2024 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 5, 2024 |
Financial Forecast
Revenue This Year
450.81M
from 53.76M
Increased by 738.59%
Revenue Next Year
56.83M
from 450.81M
Decreased by -87.39%
EPS This Year
0.76
from -1.18
EPS Next Year
-0.52
from 0.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 570.2M | 162.8M | 158.6M | |||
| Avg | 450.8M | 56.8M | 119.0M | |||
| Low | n/a | n/a | 91.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 960.6% | -63.9% | 179.0% | |||
| Avg | 738.6% | -87.4% | 109.4% | |||
| Low | - | - | 60.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.21 | -0.12 | -0.13 |
| Avg | 0.76 | -0.52 | -0.29 |
| Low | 0.50 | -0.74 | -0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.